Long term effects of denufosol tetrasodium in patients with cystic fibrosis.
J Cyst Fibros. 2012 Jun 8
Michael Schechter
07 Aug 2012
|
Clinical Trial, Refutation
Denufosol stimulates chloride secretion via an alternative channel and phase 2 studies had suggested clinical efficacy in cystic fibrosis (CF). This paper reports the results of the international phase 3 clinical trial of denufosol, which failed to demonstrate efficacy as represented by a change in forced expiratory volume in one...
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
If you think you should be able to access this content, please contact us.